Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation

[Image: see text] Serological tests are essential for the control and management of COVID-19 pandemic (diagnostics and surveillance, and epidemiological and immunity studies). We introduce a direct serological biosensor assay employing proprietary technology based on plasmonics, which offers rapid (...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvo-Lozano, Olalla, Sierra, Miquel, Soler, Maria, Estévez, Maria Carmen, Chiscano-Camón, Luis, Ruiz-Sanmartin, Adolfo, Ruiz-Rodriguez, Juan Carlos, Ferrer, Ricard, González-López, Juan José, Esperalba, Juliana, Fernández-Naval, Candela, Bueno, Leticia, López-Aladid, Ruben, Torres, Antoni, Fernández-Barat, Laia, Attoumani, Sarah, Charrel, Rémi, Coutard, Bruno, Lechuga, Laura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751014/
https://www.ncbi.nlm.nih.gov/pubmed/34971311
http://dx.doi.org/10.1021/acs.analchem.1c03850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751014/
https://www.ncbi.nlm.nih.gov/pubmed/34971311
http://dx.doi.org/10.1021/acs.analchem.1c03850

Ejemplares similares